Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
US
Sandoz Site Directory
Our Work
What We Do
Disease Areas
Quality Generics
Biosimilars
Access to Healthcare
About Us
Who We Are
Where We Do Business
Corporate Responsibility
For Novartis Investors
Contact Us
Doing Business Responsibly
Patients & Customers
Report Side Effects
Product Safety Notices
Information for Customers
Products
News
US Press Releases & News
Media Contacts
Publications
Careers
Job Search
Working at Sandoz US
Diversity & Inclusion
Search
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Filter By
2019
May
Media Release
/
May 29, 2019
Sandoz launches Fulvestrant Injection, the first generic version of FASLODEX®, in the US
Read More
Media Release
/
May 08, 2019
Update on SYMJEPI™ (epinephrine) in the US
Read More
Featured News
/
May 03, 2019
Food Allergy Awareness Week - Addressing the Medication Shortage
Read More
April
Media Release
/
Apr 03, 2019
Sandoz resubmits biosimilar pegfilgrastim application to US FDA
Read More
March
Media Release
/
Mar 26, 2019
Sandoz exclusively launches treprostinil injection, the first generic version of Remodulin®, in the US
Read More
February
Media Release
/
Feb 19, 2019
Sandoz launches authorized generic version of buprenorphine and naloxone sublingual film
Read More
January
Media Release
/
Jan 31, 2019
Sandoz US recognized as Top Employer for 2019
Read More
Media Release
/
Jan 24, 2019
Sandoz launches Desflurane, the first generic of Suprane®, in the US
Read More
Media Release
/
Jan 16, 2019
Sandoz Inc. launches SYMJEPI™ (epinephrine) in the US
Read More
Media Release
/
Jan 16, 2019
Sandoz selects three finalists for Healthcare Access Challenge (Sandoz HACk) from over 400 global entries
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
…
Page
2
of 5
Page
3
of 5
Current page
4
of 5
Page
5
of 5
Page
6
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Jump to Comments
Print
Save
You are here
Home
›
News
›
